NCT01573663View on ClinicalTrials.gov

A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

Ambroxol and Levodropropizine

Ambroxol HCl 30mg \& Levodropropizine 60mg, PO, Single dose

DRUG

Ambroxol

Ambroxol HCl 30mg, PO, single dose

DRUG

Levodropropizine

Levodropropizine 60mg, PO, single dose

Trial Locations (1)

Unknown

Samsung medical center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01573663 - A Drug-Drug Interaction Study of Ambroxol and Levodropropizine | Biotech Hunter | Biotech Hunter